Hypertensive thalamic hemorrhage
Conditions
Interventions
1)Medical treatment group All patients recieved antifibrinolytic agents, antiheypertensive substances and rehabilitation therapy. External ventricular drainage or VP shunt are not prohibit.
2)Endosc
Sponsors
Department of Neurosurgery, Hirosaki University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The patient's age was between 20 and 80 years. 2) Gender unquestioned. 3) The patients GCS 9 to 13. Or, The patients over GCS 14 with neurological deficit. 4) The volume of the hematoma was greater than 10ml. 5) The interval between stroke and start of treatment was less than 48 hours. 6) The patients take anti-platelet agent or anti-coagulate agent were not excluded.
Exclusion criteria
Exclusion criteria: 1) GCS,<8 2) Non-hyper tensive thalamic hemorrhage (aneurysmal or alteriovenous hemorrhage, postraumatic intracerebral hematomas, tumor bleeding, and bleeding tendencies caused by uremia or liver cirrhosis ) 3) Hemorrhage include brain stem.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Outcome evaluation with modified Rankin Scale and Glasgow Outcome Scale at 6 months. 2) Outcome evaluation with FIM and Brunnstrom stage at 6 months. | — |
Countries
Japan
Contacts
Public ContactKosuke Katayama
Hirosaki University Graduate School of Medicine Department of Neurosurgery
Outcome results
None listed